SRx Health Solutions Invests in Uber Technologies, Inc. and Provides Shareholders with Portfolio Update
Rhea-AI Summary
SRx Health Solutions (NYSE American: SRXH) and EMJ Crypto Technologies (EMJX) updated their portfolio and merger progress.
The firms initiated a new investment in Uber Technologies, reduced their long position in Compass, trimmed short exposure to Bitcoin, and added selective international hedges as the EMJX stress model shifted to STRESS from MIXED, the first negative reading since April 4, 2026. SRx also filed a Form S-4 Registration Statement with the SEC related to its definitive merger agreement with EMJX.
Positive
- Definitive merger agreement in place with EMJ Crypto Technologies
- Filed Form S-4 Registration Statement with SEC for proposed merger
- Initiated new Uber Technologies position as part of portfolio strategy
- Active risk management via reduced Compass exposure and added international hedges
Negative
- EMJX stress model shifted to STRESS, first negative reading since April 4, 2026
News Market Reaction – SRXH
On the day this news was published, SRXH declined 4.74%, reflecting a moderate negative market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $3M from the company's valuation, bringing the market cap to $65.40M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 21 | Psychedelics investment | Positive | +9.8% | Investment in Optimi Health IPO via EMJX-driven idea generation. |
| May 15 | Profit dividend plan | Positive | -9.4% | Board approval to dividend 75% of profits from Astro Investment XVII. |
| May 14 | Q2 2026 earnings | Positive | -9.4% | Revenue growth and loss improvement with stronger cash position from financings. |
| May 13 | AI/space investment | Positive | +25.8% | More than 10% of investable capital allocated to Astro Investment XVII. |
| Apr 22 | AI/space allocation | Positive | +1.7% | Greater than 10% of investable capital invested in Astro Investment XVII. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news has been consistently growth- and transaction-focused. The stock often moved higher on AI/space and psychedelic investment announcements but showed negative reactions around capital-return and earnings news, indicating mixed alignment between fundamentals messaging and price.
Over the last few months, SRx Health issued multiple updates linking its pet-focused operations with digital-asset and venture-style investments. On Apr 22, the company disclosed investing over 10% of investable capital into Astro Investment XVII, followed by additional AI/space updates and an EMJX-focused S-4. Earnings on May 14 showed revenue growth and improved losses, while later announcements highlighted capital-return intentions and new positions like Optimi Health. Today’s Uber-related portfolio update continues this pattern of active, thematically driven capital deployment alongside the pending EMJX merger.
Key Terms
registration statement regulatory
form s-4 regulatory
information statement/prospectus regulatory
prospectus regulatory
securities act regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
Reduced long position in Compass, Inc., reduced short exposure to Bitcoin and added selective hedges in select international markets
EMJX stress model turned STRESS from MIXED this week – the first negative market reading since the bull rotation beginning on April 4, 2026
NORTH PALM BEACH, Fla., May 29, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today provided an update on its portfolio, including the initiation of an investment in Uber Technologies, Inc.
"This week, we initiated a position in Uber Technologies as part of our repositioning across select, high-conviction assets within our portfolio," said Michael Young, Board Member at SRx Health Solutions. "We've reduced our long position in Compass, trimmed our short exposure to Bitcoin, and layered in selective hedges across a few international markets. These moves reflect a more cautious posture, as our EMJX stress model has shifted to STRESS from MIXED this week, the first negative market reading we've seen since the bull rotation on April 4, 2026, and we're managing the book accordingly."
"Our job isn't to predict the market — it's to respect it. When the model turns to STRESS, that's the signal to lead with risk management and protect capital before the risk shows up in prices. Acting early and defensively every time the regime turns is the discipline we're building this Gen2 EMJX platform on." — Eric Jackson, Founder of EMJX.
SRx Health Solutions and EMJX continue to actively manage the portfolio with an emphasis on balancing growth opportunities against disciplined risk management.
Additional Information and Where to Find It
In connection with the proposed transaction between the Company has filed with the SEC a Registration Statement on Form S-4 (the "Registration Statement") to register the common stock to be issued in connection with the proposed transaction. The Registration Statement includes an information statement of the Company and a prospectus of the Company (the "Information Statement/Prospectus"), and each of EMJX and the Company may file with the SEC other relevant documents concerning the proposed transaction. After the Registration Statement is declared effective, the definitive Information Statement/Prospectus will be sent to the stockholders This is not a substitute for the Registration Statement, the Information Statement/Prospectus or any other relevant documents that EMJX or the Company has filed or will file with the SEC. BEFORE MAKING ANY INVESTMENT DECISION, INVESTORS AND STOCKHOLDERS OF THE COMPANY ARE URGED TO CAREFULLY AND ENTIRELY READ THE REGISTRATION STATEMENT AND INFORMATION STATEMENT/PROSPECTUS REGARDING THE PROPOSED TRANSACTION AND ANY OTHER RELEVANT DOCUMENTS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, IF AND WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT EMJX, THE COMPANY, THE PROPOSED TRANSACTION, AND RELATED MATTERS. A copy of the Registration Statement, Information Statement/Prospectus, as well as other relevant documents filed by EMJX and the Company with the SEC, may be obtained free of charge, when they become available, at the SEC's website at www.sec.gov. The information on EMJX's or the Company's respective websites is not, and shall not be deemed to be, a part of this communication or incorporated into other filings either company makes with the SEC.
No Offer or Solicitation
This communication is for informational purposes only and is not intended to and does not constitute an offer to sell or the solicitation of an offer to buy or sell any securities or the solicitation of any proxy, vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, or in a transaction exempt from the registration requirements of the Securities Act.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "believe," "expect," "intend," "aim," "plan," "may," "could," "target," and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, but are not limited to, the ability to complete the proposed transaction, shareholder approvals, market conditions, regulatory considerations, and other risks described in the Company's filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.
Company Contact
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer
Investor Relations Contact
KCSA Strategic Communications
Valter Pinto, Managing Director
212-896-1254
valter@kcsa.com
